{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:16:54Z","timestamp":1792815414011,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.mcna.2021.09.002","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T16:59:26Z","timestamp":1637600366000},"page":"201-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Harm Reduction in Health Care Settings"],"prefix":"10.1016","volume":"106","author":[{"given":"Carolyn A.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Canver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly L.","family":"Sue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mcna.2021.09.002_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/09595239500185371","article-title":"Defining harm reduction","volume":"14","author":"Single","year":"1995","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.mcna.2021.09.002_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12954-019-0285-7","article-title":"\u201cMaybe if I stop the drugs, then maybe they\u2019d care?\u201d\u2014hospital care experiences of people who use drugs","volume":"16","author":"Chan Carusone","year":"2019","journal-title":"Harm Reduct J"},{"issue":"4","key":"10.1016\/j.mcna.2021.09.002_bib3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/08897077.2019.1671942","article-title":"Understanding why patients with substance use disorders leave the hospital against medical advice: a qualitative study","volume":"41","author":"Simon","year":"2020","journal-title":"Subst Abuse"},{"key":"10.1016\/j.mcna.2021.09.002_bib4","first-page":"100029","article-title":"A\u00a0systematic literature review of patient perspectives of barriers and facilitators to access, adherence, stigma, and persistence to treatment for substance use disorder","volume":"2","author":"Cernasev","year":"2021","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"1","key":"10.1016\/j.mcna.2021.09.002_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/JAN.0000000000000215","article-title":"Racialized mass incarceration and the war on drugs: a critical race theory appraisal","volume":"29","author":"Fornili","year":"2018","journal-title":"J\u00a0Addict Nurs"},{"key":"10.1016\/j.mcna.2021.09.002_bib6","doi-asserted-by":"crossref","first-page":"108651","DOI":"10.1016\/j.drugalcdep.2021.108651","article-title":"Barriers to accessing opioid substitution treatment for opioid use disorder: a systematic review from the client perspective","volume":"221","author":"Hall","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"10.1016\/j.mcna.2021.09.002_bib7","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.2105\/AJPH.2015.302885","article-title":"Leaving the hospital against medical advice among people who use illicit drugs: a systematic review","volume":"105","author":"Ti","year":"2015","journal-title":"Am J Public Health"},{"key":"10.1016\/j.mcna.2021.09.002_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.socscimed.2014.01.010","article-title":"Hospitals as a \u2018risk environment\u2019: an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs","volume":"105","author":"McNeil","year":"2014","journal-title":"Soc Sci Med"},{"issue":"4","key":"10.1016\/j.mcna.2021.09.002_bib9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/add.13214","article-title":"Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals","volume":"111","author":"McNeil","year":"2016","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.mcna.2021.09.002_bib10","first-page":"1","article-title":"Drugs most frequently involved in drug overdose deaths: United States, 2011-2016","volume":"67","author":"Hedegaard","year":"2018","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.mcna.2021.09.002_bib11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.drugpo.2019.10.004","article-title":"Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs","volume":"74","author":"Lambdin","year":"2019","journal-title":"Int J Drug Policy"},{"issue":"5","key":"10.1016\/j.mcna.2021.09.002_bib12","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","article-title":"Hospitalizations related to opioid abuse\/dependence and associated serious infections increased sharply, 2002\u201312","volume":"35","author":"Ronan","year":"2016","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"10.1016\/j.mcna.2021.09.002_bib13","first-page":"14","article-title":"Updating the infection risk reduction hierarchy: Preventing transition into injection","volume":"81","author":"Vlahov","year":"2004","journal-title":"J\u00a0Urban Health Bull N Y Acad Med"},{"issue":"3","key":"10.1016\/j.mcna.2021.09.002_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/10550887.2011.581989","article-title":"Comparing injection and non-injection routes of administration for heroin, methamphetamine, and cocaine uses in the United States","volume":"30","author":"Novak","year":"2011","journal-title":"J\u00a0Addict Dis"},{"issue":"2","key":"10.1016\/j.mcna.2021.09.002_bib15","first-page":"189","article-title":"Heroin overdose: research and evidence-based intervention","volume":"80","author":"Darke","year":"2003","journal-title":"J\u00a0Urban Health Bull N Y Acad Med"},{"issue":"1","key":"10.1016\/j.mcna.2021.09.002_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14659890410001665041","article-title":"Injection preparation processes used by heroin and crack cocaine injectors","volume":"9","author":"Ponton","year":"2004","journal-title":"J\u00a0Subst Use"},{"issue":"2","key":"10.1016\/j.mcna.2021.09.002_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0955-3959(02)00007-5","article-title":"The \u2018risk environment\u2019: a framework for understanding and reducing drug-related harm","volume":"13","author":"Rhodes","year":"2002","journal-title":"Int J Drug Policy"},{"issue":"3","key":"10.1016\/j.mcna.2021.09.002_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugpo.2008.10.003","article-title":"Risk environments and drug harms: a social science for harm reduction approach","volume":"20","author":"Rhodes","year":"2009","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.mcna.2021.09.002_bib20","series-title":"Effectiveness of sterile needle and syringe programming in reducing HIV\/AIDS among injecting drug users","year":"2004"},{"issue":"1","key":"10.1016\/j.mcna.2021.09.002_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/08897077.2016.1263592","article-title":"Behavioral characteristics and injection practices associated with skin and soft tissue infections among people who inject drugs: a community-based observational study","volume":"38","author":"Dahlman","year":"2017","journal-title":"Subst Abuse"},{"issue":"4","key":"10.1016\/j.mcna.2021.09.002_bib22","first-page":"313","article-title":"Eikenella corrodens endocarditis in an intravenous drug user: case report and literature review","volume":"86","author":"Olopoenia","year":"1994","journal-title":"J\u00a0Natl Med Assoc"},{"issue":"4","key":"10.1016\/j.mcna.2021.09.002_bib23","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1097\/QAI.0000000000002063","article-title":"Heating injection drug preparation equipment used for opioid injection may reduce HIV transmission associated with sharing equipment","volume":"81","author":"Ball","year":"2019","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.mcna.2021.09.002_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2105\/AJPH.91.1.42","article-title":"Sharing of drug preparation equipment as a risk factor for hepatitis C","volume":"91","author":"Hagan","year":"2001","journal-title":"Am J Public Health"},{"issue":"8","key":"10.1016\/j.mcna.2021.09.002_bib25","doi-asserted-by":"crossref","first-page":"e0219777","DOI":"10.1371\/journal.pone.0219777","article-title":"A\u00a0controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk","volume":"14","author":"Kasper","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.mcna.2021.09.002_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1477-7517-8-20","article-title":"The filter of choice: filtration method preference among injecting drug users","volume":"8","author":"Keijzer","year":"2011","journal-title":"Harm Reduct J"},{"issue":"1","key":"10.1016\/j.mcna.2021.09.002_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/dar.12196","article-title":"Filtration of crushed tablet suspensions has potential to reduce infection incidence in people who inject drugs","volume":"34","author":"Ng","year":"2015","journal-title":"Drug Alcohol Rev"},{"issue":"5","key":"10.1016\/j.mcna.2021.09.002_bib28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1081\/JA-100103561","article-title":"Different forms of heroin and their relationship to cook-up techniques: data on, and explanation of, use of lemon juice and other acids","volume":"36","author":"Strang","year":"2001","journal-title":"Subst Use Misuse"},{"issue":"1","key":"10.1016\/j.mcna.2021.09.002_bib29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12954-019-0330-6","article-title":"Injecting-related health harms and overuse of acidifiers among people who inject heroin and crack cocaine in London: a mixed-methods study","volume":"16","author":"Harris","year":"2019","journal-title":"Harm Reduct J"},{"issue":"5","key":"10.1016\/j.mcna.2021.09.002_bib30","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/add.15236","article-title":"Skin-cleaning among hospitalized people who inject drugs: a randomized controlled trial","volume":"116","author":"Stein","year":"2021","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.mcna.2021.09.002_bib31","first-page":"595","article-title":"Bacterial infections and skin cleaning prior to injection among intravenous drug users","volume":"107","author":"Vlahov","year":"1992","journal-title":"Public Health Rep"},{"key":"10.1016\/j.mcna.2021.09.002_bib32","doi-asserted-by":"crossref","first-page":"108646","DOI":"10.1016\/j.drugalcdep.2021.108646","article-title":"A\u00a0randomized controlled trial of a brief behavioral intervention to reduce skin and soft tissue infections among people who inject drugs","volume":"221","author":"Phillips","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"9883","key":"10.1016\/j.mcna.2021.09.002_bib34","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.mcna.2021.09.002_bib35","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1517\/14740338.2015.1037274","article-title":"Reducing the harm of opioid overdose with the safe use of naloxone\u202f: a pharmacologic review","volume":"14","author":"Kim","year":"2015","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"10.1016\/j.mcna.2021.09.002_bib36","doi-asserted-by":"crossref","first-page":"765","DOI":"10.7326\/0003-4819-85-6-765","article-title":"Naloxone","volume":"85","author":"Martin","year":"1976","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2021.09.002_bib37","doi-asserted-by":"crossref","first-page":"107536","DOI":"10.1016\/j.drugalcdep.2019.06.038","article-title":"Impact of a community-based naloxone distribution program on opioid overdose death rates","volume":"204","author":"Naumann","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.mcna.2021.09.002_bib38","doi-asserted-by":"crossref","first-page":"f174","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.mcna.2021.09.002_bib39","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugpo.2017.06.005","article-title":"Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic","volume":"46","author":"Fairbairn","year":"2017","journal-title":"Int J Drug Policy"},{"issue":"6","key":"10.1016\/j.mcna.2021.09.002_bib40","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/jamainternmed.2019.0272","article-title":"Association between state laws facilitating pharmacy distribution of naloxone and risk of fatal overdose","volume":"179","author":"Abouk","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.mcna.2021.09.002_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/15563650.2019.1615622","article-title":"Prepacked naloxone administration for suspected opioid overdose in the era of illicitly manufactured fentanyl: a retrospective study of regional poison center data","volume":"58","author":"Mahonski","year":"2020","journal-title":"Clin Toxicol"},{"issue":"1","key":"10.1016\/j.mcna.2021.09.002_bib42","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/08897077.2018.1449053","article-title":"Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply","volume":"40","author":"Bell","year":"2019","journal-title":"Subst Abuse"},{"issue":"3","key":"10.1016\/j.mcna.2021.09.002_bib43","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2105\/AJPH.2008.136937","article-title":"Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality","volume":"99","author":"Kim","year":"2009","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.mcna.2021.09.002_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.15585\/mm6604a4","article-title":"Multiple Fentanyl Overdoses - New Haven, Connecticut, June 23, 2016","volume":"66","author":"Tomassoni","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.mcna.2021.09.002_bib45","doi-asserted-by":"crossref","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and Opioid-Involved Overdose Deaths \u2014 United States, 2017\u20132018","volume":"69","author":"Wilson","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.mcna.2021.09.002_bib46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.drugpo.2018.04.017","article-title":"Fentanyl self-testing outside supervised injection settings to prevent opioid overdose: do we know enough to promote it?","volume":"58","author":"McGowan","year":"2018","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.mcna.2021.09.002_bib47","doi-asserted-by":"crossref","first-page":"103065","DOI":"10.1016\/j.drugpo.2020.103065","article-title":"Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs","volume":"90","author":"Bergh","year":"2021","journal-title":"Int J Drug Policy"},{"issue":"2","key":"10.1016\/j.mcna.2021.09.002_bib48","first-page":"95","article-title":"Defining low-threshold buprenorphine treatment","volume":"14","author":"Jakubowski","year":"2020","journal-title":"J\u00a0Addict Med"},{"issue":"3","key":"10.1016\/j.mcna.2021.09.002_bib49","first-page":"177","article-title":"Opiate-dependent patients on a waiting list for methadone maintenance treatment are at high risk for mortality until treatment entry","volume":"7","author":"Peles","year":"2013","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.mcna.2021.09.002_bib50","doi-asserted-by":"crossref","first-page":"108011","DOI":"10.1016\/j.jsat.2020.108011","article-title":"Appointment wait-times and arrival for patients at a low-barrier access addiction clinic","volume":"114","author":"Roy","year":"2020","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"9","key":"10.1016\/j.mcna.2021.09.002_bib51","doi-asserted-by":"crossref","first-page":"628","DOI":"10.7326\/M18-1652","article-title":"The next stage of buprenorphine care for opioid use disorder","volume":"169","author":"Martin","year":"2018","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.mcna.2021.09.002_bib52","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1016\/S2352-3018(15)00129-0","article-title":"Effect of low-threshold methadone maintenance therapy for people who inject drugs on HIV incidence in Vancouver, BC, Canada: an observational cohort study","volume":"2","author":"Ahamad","year":"2015","journal-title":"Lancet HIV"},{"key":"10.1016\/j.mcna.2021.09.002_bib53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drugalcdep.2015.08.037","article-title":"The impact of low-threshold methadone maintenance treatment on mortality in a Canadian setting","volume":"156","author":"Nolan","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.mcna.2021.09.002_bib54","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1521\/aeap.2007.19.2.124","article-title":"Reduction in injection-related HIV risk after 6\u00a0months in a low-threshold methadone treatment program","volume":"19","author":"Millson","year":"2007","journal-title":"AIDS Educ Prev"},{"key":"10.1016\/j.mcna.2021.09.002_bib55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jsat.2019.06.015","article-title":"Implementation and evaluation of Missouri\u2019s Medication First treatment approach for opioid use disorder in publicly-funded substance use treatment programs","volume":"108","author":"Winograd","year":"2020","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"4","key":"10.1016\/j.mcna.2021.09.002_bib56","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/00952990.2019.1605372","article-title":"The case for a medication first approach to the treatment of opioid use disorder","volume":"45","author":"Winograd","year":"2019","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.mcna.2021.09.002_bib57","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/0003-4819-144-2-200601170-00010","article-title":"Acute pain management for patients receiving maintenance methadone or buprenorphine therapy","volume":"144","author":"Alford","year":"2006","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.mcna.2021.09.002_bib58","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3109\/10826084.2014.891616","article-title":"Alcohol consumption, dependence, and treatment barriers: perceptions among nontreatment seekers with alcohol dependence","volume":"49","author":"Wallhed Finn","year":"2014","journal-title":"Subst Use Misuse"},{"issue":"10","key":"10.1016\/j.mcna.2021.09.002_bib59","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.ebiom.2015.08.040","article-title":"Risk of all-cause mortality in alcohol-dependent individuals: a systematic literature review and meta-analysis","volume":"2","author":"Laram\u00e9e","year":"2015","journal-title":"EBioMedicine"},{"issue":"0 1","key":"10.1016\/j.mcna.2021.09.002_bib60","first-page":"E373","article-title":"Posttreatment low-risk drinking as a predictor of future drinking and problem outcomes among individuals with alcohol use disorders","volume":"37","author":"Kline-Simon","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"issue":"S1","key":"10.1016\/j.mcna.2021.09.002_bib61","first-page":"S132","article-title":"Community managed alcohol programs in Canada: overview of key dimensions and implementation","volume":"37","author":"Bernie","year":"2018","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"10.1016\/j.mcna.2021.09.002_bib62","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12954-016-0103-4","article-title":"Do managed alcohol programs change patterns of alcohol consumption and reduce related harm? A pilot study","volume":"13","author":"Vallance","year":"2016","journal-title":"Harm Reduct J"},{"issue":"1","key":"10.1016\/j.mcna.2021.09.002_bib63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12954-016-0102-5","article-title":"Finding safety: a pilot study of managed alcohol program participants\u2019 perceptions of housing and quality of life","volume":"13","author":"Bernie","year":"2016","journal-title":"Harm Reduct J"},{"issue":"10209","key":"10.1016\/j.mcna.2021.09.002_bib64","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/S0140-6736(19)32230-5","article-title":"Responding to global stimulant use: challenges and opportunities","volume":"394","author":"Farrell","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2021.09.002_bib66","doi-asserted-by":"crossref","first-page":"108416","DOI":"10.1016\/j.drugalcdep.2020.108416","article-title":"Fentanyl and fentanyl analogs in the illicit stimulant supply: Results from U.S. drug seizure data, 2011\u20132016","volume":"218","author":"Park","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"10.1016\/j.mcna.2021.09.002_bib67","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1503\/cmaj.082054","article-title":"Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs","volume":"181","author":"DeBeck","year":"2009","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.mcna.2021.09.002_bib68","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/MEG.0b013e3282f16a8c","article-title":"Hepatitis C virus transmission among oral crack users: viral detection on crack paraphernalia","volume":"20","author":"Fischer","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.mcna.2021.09.002_bib69","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-145-1-200607040-00018","article-title":"Transrectal methamphetamine use: a novel route of exposure","volume":"145","author":"Cantrell","year":"2006","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.mcna.2021.09.002_bib70","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ije\/dyt243","article-title":"Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis","volume":"43","author":"Aspinall","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"3","key":"10.1016\/j.mcna.2021.09.002_bib71","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0740-5472(00)00104-5","article-title":"Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors","volume":"19","author":"Hagan","year":"2000","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"17","key":"10.1016\/j.mcna.2021.09.002_bib72","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/jama.2009.561","article-title":"Effect of a housing and case management program on emergency department visits and hospitalizations among chronically ill homeless adults: a randomized trial","volume":"301","author":"Sadowski","year":"2009","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mcna.2021.09.002_bib73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.drugpo.2007.11.006","article-title":"Harm reduction headway and continuing resistance: Insights from safe injection in the city of Vancouver","volume":"19","author":"Hathaway","year":"2008","journal-title":"Int J Drug Policy"},{"issue":"6","key":"10.1016\/j.mcna.2021.09.002_bib74","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMc2015435","article-title":"Evaluation of an unsanctioned safe consumption site in the United States","volume":"383","author":"Kral","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2021.09.002_bib75","author":"Mulvaney"},{"issue":"1","key":"10.1016\/j.mcna.2021.09.002_bib76","first-page":"35","article-title":"Changes in injecting practices associated with the use of a medically supervised safer injection facility","volume":"29","author":"Stoltz","year":"2007","journal-title":"J\u00a0Public Health"},{"issue":"23","key":"10.1016\/j.mcna.2021.09.002_bib77","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1056\/NEJMc052939","article-title":"Attendance at supervised injecting facilities and use of detoxification services","volume":"354","author":"Wood","year":"2006","journal-title":"N\u00a0Engl J Med"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571252100122X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571252100122X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:45:57Z","timestamp":1758419157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002571252100122X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S002571252100122X"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2021.09.002","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harm Reduction in Health Care Settings","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2021.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}